- Indicators of clinical activity in multiple sclerosis and their influence treatment2014 | Faculty of Medicine in Hradec Králové
- A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase II Study of Subcutaneously Administered Interferon Beta 1a in the Treatment of Patiens with Aktive Rheumatoid ArthritisPublication without faculty affiliation